QIBA 膝关节软骨 MRI 成分成像规范
该文介绍 QIBA 肌骨生物标志物委员会制定的膝关节软骨成分成像规范,针对 T1ρ 和 T2 mapping 的可重复性提出两项声明:3.0-T MRI 上 T1ρ 和 T2 值的受试者内变异系数为 4%-5%;T1ρ 和 T2 变化达 14% 或以上表示 95% 置信度下的最小可检测变化,若仅预期升高则 12% 即为最小可检测变化。规范还就数据采集、分析和解读及重测一致性提供建议。
要点
- T2 mapping 对水、胶原含量及纤维方向敏感,T1ρ 对蛋白聚糖含量更敏感。
- 3.0-T MRI 上 T1ρ 和 T2 值的受试者内变异系数为 4%-5%。
- T1ρ 和 T2 变化≥14% 为 95% 置信度最小可检测变化,仅预期升高时 12% 即可。
关键影像表现/征象
- T2 mapping 对水、胶原含量及胶原纤维方向敏感,T1ρ 对蛋白聚糖含量更敏感。
- 成分成像可在结构 MRI 序列和关节镜检查发现变化之前显示骨关节炎早期的生化及微结构改变。
诊断标准与关键数值
- 3.0-T MRI 上软骨 T1ρ 和 T2 值的受试者内变异系数为 4%-5%。
- T1ρ 和 T2 测量值升高或降低 14% 或以上表示 95% 置信度下的最小可检测变化。
- 若仅预期 T1ρ 和 T2 值升高(进行性软骨退变),则升高 12% 代表随时间的最小可检测变化。
临床应用与阅片要点
- 临床科研中可按 QIBA 规范进行 T1ρ 和 T2 软骨成像的采集、分析、解读及重测一致性评估。
- 判读系列随访时注意:变化需达到 14%(双向)或 12%(仅升高)才视为超过测量误差的最小可检测变化。
局限性
- 原文指出软骨成分成像生物标志物变异性高、可重复性欠佳,限制其临床应用。
- 目前仅 T2 mapping 已商业化可用,T1ρ 尚未商业化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
MRI-based cartilage compositional analysis shows biochemical and microstructural changes at early stages of osteoarthritis before changes become visible with structural MRI sequences and arthroscopy. This could help with early diagnosis, risk assessment, and treatment monitoring of osteoarthritis. Spin-lattice relaxation time constant in rotating frame (T1ρ) and T2 mapping are the MRI techniques best established for assessing cartilage composition. Only T2 mapping is currently commercially available, which is sensitive to water, collagen content, and orientation of collagen fibers, whereas T1ρ is more sensitive to proteoglycan content. Clinical application of cartilage compositional imaging is limited by high variability and suboptimal reproducibility of the biomarkers, which was the motivation for creating the Quantitative Imaging Biomarkers Alliance (QIBA) Profile for cartilage compositional imaging by the Musculoskeletal Biomarkers Committee of the QIBA. The profile aims at providing recommendations to improve reproducibility and to standardize cartilage compositional imaging. The QIBA Profile provides two complementary claims (summary statements of the technical performance of the quantitative imaging biomarkers that are being profiled) regarding the reproducibility of biomarkers. First, cartilage T1ρ and T2 values are measurable at 3.0-T MRI with a within-subject coefficient of variation of 4%-5%. Second, a measured increase or decrease in T1ρ and T2 of 14% or more indicates a minimum detectable change with 95% confidence. If only an increase in T1ρ and T2 values is expected (progressive cartilage degeneration), then an increase of 12% represents a minimum detectable change over time. The QIBA Profile provides recommendations for clinical researchers, clinicians, and industry scientists pertaining to image data acquisition, analysis, and interpretation and assessment procedures for T1ρ and T2 cartilage imaging and test-retest conformance. This special report aims to provide the rationale for the proposed claims, explain the content of the QIBA Profile, and highlight the future needs and developments for MRI-based cartilage compositional imaging for risk prediction, early diagnosis, and treatment monitoring of osteoarthritis.
引用
- Chalian M, Li X, Guermazi A, et al. The QIBA Profile for MRI-based Compositional Imaging of Knee Cartilage. Radiology. 2021. PMID: 34491127. doi:10.1148/radiol.2021204587
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。